EVALUATION OF THE COST, EFFECTIVENESS AND SATISFACTION OF ACTORS IN A HOME BLOOD GLUCOSE MONITORING: PROGRAMA DE MONITORIZAÇÃO GLICÊMICA DOMICILIAR
Introduction: Glycemic monitoring is a strategy that promotes education for supported self-care and the effective participation of individuals who are susceptible or have diabetes mellitus. Objective: To evaluate the cost, effectiveness and satisfaction of actors in a home glycemic monitoring progra...
| Autores: | , , , , , |
|---|---|
| Tipo de recurso: | artículo |
| Estado: | Versión publicada |
| Fecha de publicación: | 2023 |
| País: | Brasil |
| Institución: | Sociedade Brasileira de Enfermagem em Feridas e Estética (SOBENFeE) |
| Repositorio: | Revista Enfermagem Atual In Derme |
| Idioma: | portugués |
| OAI Identifier: | oai:revistae_ojs.revistaenfermagematual.a2hosted.com:article/1932 |
| Acceso en línea: | https://revistaenfermagematual.com/index.php/revista/article/view/1932 |
| Access Level: | acceso abierto |
| Palabra clave: | Diabetes Mellitus Automonitorização da Glicemia Avaliação de Programas Blood Glucose Self-Monitoring Program Evaluation Automonitorización de la Glucosa Sanguínea Evaluación de Programas y Proyectos de Salud |
| Sumario: | Introduction: Glycemic monitoring is a strategy that promotes education for supported self-care and the effective participation of individuals who are susceptible or have diabetes mellitus. Objective: To evaluate the cost, effectiveness and satisfaction of actors in a home glycemic monitoring program. Method: Sequential mixed method study, from 2019 to 2021. In phases 1 and 2, quantitative data, a micro-funding study was carried out. The results of the program were analyzed through document analysis, identifying the absolute and relative frequency of dependent and independent variables, with mean and standard deviation being calculated. In phase 3, qualitative data, the strengths and weaknesses of the program were evaluated. In the analysis, the data quantitative and qualitative were connected. Results: The monthly cost of the patient who received 50 and 100 units of supplies was R$89.89 (U$17.29) and R$147.99 (U$28.46), respectively. A total of 659 patients were evaluated, with a reduction of 0.84% in glycated hemoglobin and a reduction of 23.29 mg/dl in fasting glucose. As potentialities, stands out the free availability of inputs stands out; aid in therapeutic management; development of skills for self-care. As weakness, stands out bureaucracy and rigor in the control and distribution of inputs; difficulty understanding and correctly adhering to blood glucose monitoring; lack of expanded multidisciplinary team in care; and the need for technological improvements for analysis and monitoring of results. Conclusion: The costs related to the program can be a positive investment, demonstrated by the satisfaction of the actors, which presented a balance between strengths and weaknesses. |
|---|